NLRP3 and congenital rubella syndrome: To verify whether Cathepsin B/NLRP3 signaling pathways are involved in CRS-induced hippocampal microglia pyroptosis, Nitroxoline, and MCC950 were used to inhibit Cathepsin B and NLRP3, respectively.